Correlation Between Corbion NV and Pharming Group

Can any of the company-specific risk be diversified away by investing in both Corbion NV and Pharming Group at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Corbion NV and Pharming Group into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Corbion NV and Pharming Group NV, you can compare the effects of market volatilities on Corbion NV and Pharming Group and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Corbion NV with a short position of Pharming Group. Check out your portfolio center. Please also check ongoing floating volatility patterns of Corbion NV and Pharming Group.

Diversification Opportunities for Corbion NV and Pharming Group

0.22

Correlation Coefficient

Corbion NV  Pharming Group

Modest diversification

The 3 months correlation between Corbion and Pharming is 0.22. Overlapping area represents the amount of risk that can be diversified away by holding Corbion NV and Pharming Group NV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pharming Group NV and Corbion NV is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Corbion NV are associated (or correlated) with Pharming Group. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pharming Group NV has no effect on the direction of Corbion NV i.e., Corbion NV and Pharming Group go up and down completely randomly.

Pair Corralation between Corbion NV and Pharming Group

Assuming the 90 days trading horizon Corbion NV is expected to under-perform the Pharming Group. But the stock apears to be less risky and, when comparing its historical volatility, Corbion NV is 1.98 times less risky than Pharming Group. The stock trades about -0.07 of its potential returns per unit of risk. The Pharming Group NV is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest  70.00  in Pharming Group NV on September 18, 2024 and sell it today you would earn a total of  13.00  from holding Pharming Group NV or generate 18.57% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Corbion NV  vs.  Pharming Group NV

Corbion NV

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Corbion NV has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

Pharming Group NV

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Pharming Group NV are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain basic indicators, Pharming Group sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Corbion NV and Pharming Group

The main advantage of trading using opposite Corbion NV and Pharming Group positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Corbion NV position performs unexpectedly, Pharming Group can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pharming Group will offset losses from the drop in Pharming Group's long position.

The idea behind Corbion NV and Pharming Group NV pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..